1887

Abstract

Hepatitis C virus (HCV) chronic infection has been associated with many lymphoproliferative disorders. Several studies performed on hepatoma and fibroblast cell lines suggest a role of the HCV core protein in activation of cellular transduction pathways that lead to cell proliferation and inhibition of apoptosis. However, no data are available concerning the effects of HCV core expression on B-lymphocyte proliferation and apoptosis. B-lymphocyte cell lines permanently expressing full-length HCV 1b core sequences isolated from chronically infected patients were established using B-cell lines at different degrees of differentiation. Clones and pools of clones permanently expressing the HCV core were selected and characterized for protein expression by Western blot and FACS. Expression of HCV core proteins did not significantly enhance cell proliferation rates under normal culture conditions or under mitogenic stimulation. Analysis of NF-κB, CRE, TRE and SRE pathways by luciferase reporter genes did not show a significant influence of HCV core expression on these signal transduction cascades in B-lymphocytes. The effects of HCV core on anti-IgM and anti-FAS-induced apoptosis in B-cell lines was also analysed. In this experimental model, HCV core expression did not significantly modify the apoptotic profile of the B-lymphocyte cell lines tested. These data underline a cell type-specific effect of HCV core expression. In fact, it was not possible to show a significant contribution of the HCV core protein in activation of the major B-cell signal transduction pathways involved in the regulation of proliferation and programmed cell death, which is in contrast with the results reported in hepatoma cell lines.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-7-1665
2002-07-01
2020-10-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/7/0831665a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-7-1665&mimeType=html&fmt=ahah

References

  1. Abel G., Zhang Q. X., Agnello V.. 1993; Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis and Rheumatism36:1341–1349
    [Google Scholar]
  2. Ahmed S. A., Gogal R. M. Jr, Walsh J. E.. 1994; A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. Journal of Immunological Methods170:211–224
    [Google Scholar]
  3. Andreone P., Zignego A. L., Cursaro C., Gramenzi A., Gherlinzoni F., Fiorino S., Giannini C., Boni P., Sabattini E., Pileri S., Tura S., Bernardi M.. 1998; Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. Annals of Internal Medicine129:294–298
    [Google Scholar]
  4. Aoki H., Hayashi J., Moriyama M., Arakawa Y., Hino O.. 2000; Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. Journal of Virology74:1736–1741
    [Google Scholar]
  5. Caussin-Schwemling C., Schmitt C., Stoll-Keller F.. 2001; Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro . Journal of Medical Virology65:14–22
    [Google Scholar]
  6. Chang J., Yang S. H., Cho Y. G., Hwang S. B., Hahn Y. S., Sung Y. C.. 1998; Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. Journal of Virology72:3060–3065
    [Google Scholar]
  7. Cohen J. J.. 1991; Programmed cell death in the immune system. Advances in Immunology50:55–85
    [Google Scholar]
  8. Cohen J. H., Revillard J. P., Magaud J. P., Lenoir G., Vuillaume M., Manel A. M., Vincent C., Bryon P. A.. 1987; B-cell maturation stages of Burkitt′s lymphoma cell lines according to Epstein–Barr virus status and type of chromosome translocation. Journal of the National Cancer Institute78:235–242
    [Google Scholar]
  9. Delhem N., Sabile A., Gajardo R., Podevin P., Abadie A., Blaton M. A., Kremsdorf D., Beretta L., Bréchot C.. 2001; Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein. Oncogene20:5836–5845
    [Google Scholar]
  10. Dolbeare F., Gratzner H., Pallavicini M. G., Gray J. W.. 1983; Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proceedings of the National Academy of Sciences, USA80:5573–5577
    [Google Scholar]
  11. Dumoulin F. L., van dem Bussche A., Sohne J., Sauerbruch T., Spengler U.. 1999; Hepatitis C virus core protein does not inhibit apoptosis in human hepatoma cells. European Journal of Clinical Investigations29:940–946
    [Google Scholar]
  12. Ferri C., Caracciolo F., La Civita L., Monti M., Longombardo G., Greco F., Zignego A. L.. 1994; Hepatitis C virus infection and B-cell lymphomas. European Journal of Cancer10:1591–1592
    [Google Scholar]
  13. Fukuda K., Tsuchihara K., Hijikata M., Nishiguchi S., Kuroki T., Shimotohno K.. 2001; Hepatitis C virus core protein enhances the activation of the transcription factor, Elk1, in response to mitogenic stimuli. Hepatology33:159–165
    [Google Scholar]
  14. Giambartolomei S., Covone F., Levrero M., Balsano C.. 2001; Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the hepatitis C virus (HCV) core protein. Oncogene20:2606–2610
    [Google Scholar]
  15. Hartley S. B., Cooke M. P., Fulcher D. A., Harris A. W., Cory S., Basten A., Goodnow C. C.. 1993; Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell72:325–335
    [Google Scholar]
  16. Hayashi J., Aoki H., Kajino K., Moriyama M., Arakawa Y., Hino O.. 2000; Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor α. Hepatology32:958–961
    [Google Scholar]
  17. Honda M., Kaneko S., Shimazaki T., Matsushita E., Kobayashi K., Ping L. H., Zhang H. C., Lemon S. M.. 2000; Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology31:1351–1359
    [Google Scholar]
  18. Jin D. Y., Wang H. L., Zhou Y., Chun A. C., Kibler K. V., Hou Y. D., Kung H., Jeang K. T.. 2000; Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO Journal19:729–740
    [Google Scholar]
  19. Kitay-Cohen Y., Amiel A., Hilzenrat N., Buskila D., Ashur Y., Fejgin M., Gaber E., Safadi R., Tur-Kaspa R., Lishner M.. 2000; Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood96:2910–2912
    [Google Scholar]
  20. Laskus T., Radkowski M., Piasek A., Nowicki M., Horban A., Cianciara J., Rakela J.. 2000; Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. Journal of Infectious Diseases181:442–448
    [Google Scholar]
  21. Liu Z. X., Nishida H., He J. W., Lai M. M., Feng N., Dennert G.. 2002; Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity. Journal of Virology76:990–997
    [Google Scholar]
  22. Marusawa H., Hijikata M., Chiba T., Shimotohno K.. 1999; Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor α-mediated apoptosis via NF-κB activation. Journal of Virology73:4713–4720
    [Google Scholar]
  23. Mazzocca A., Cordella C., Giannini C., Pantaleo P., Romanelli R. G., Laffi G., Gentilini P., Zignego A.. 2000; Clustering of the putative hepatitis C virus (HCV) receptor CD81 is necessary to promote B-cell proliferation and c-myc expression. Hepatology32:675
    [Google Scholar]
  24. Morsica G., Tambussi G., Sitia G., Novati R., Lazzarin A., Lopalco L., Mukenge S.. 1999; Replication of hepatitis C virus in B lymphocytes (CD19+). Blood94:1138–1139
    [Google Scholar]
  25. Ray R. B., Lagging L. M., Meyer K., Steele R., Ray R.. 1995; Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Research37:209–220
    [Google Scholar]
  26. Ray R. B., Lagging L. M., Meyer K., Ray R.. 1996a; Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. Journal of Virology70:4438–4443
    [Google Scholar]
  27. Ray R. B., Meyer K., Ray R.. 1996b; Suppression of apoptotic cell death by hepatitis C virus core protein. Virology226:176–182
    [Google Scholar]
  28. Ruggieri A., Harada T., Matsuura Y., Miyamura T.. 1997; Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology229:68–76
    [Google Scholar]
  29. Scaffidi C., Kirchhoff S., Krammer P. H., Peter M. E.. 1999; Apoptosis signaling in lymphocytes. Current Opinion in Immunology11:277–285
    [Google Scholar]
  30. Shrivastava A., Manna S. K., Ray R., Aggarwal B. B.. 1998; Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. Journal of Virology72:9722–9728
    [Google Scholar]
  31. Sirma H., Giannini C., Poussin K., Paterlini P., Kremsdorf D., Bréchot C.. 1999; Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene18:4848–4859
    [Google Scholar]
  32. Tsuchihara K., Hijikata M., Fukuda K., Kuroki T., Yamamoto N., Shimotohno K.. 1999; Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli. Virology258:100–107
    [Google Scholar]
  33. You L. R., Chen C. M., Lee Y. H.. 1999; Hepatitis C virus core protein enhances NF-κB signal pathway triggering by lymphotoxin-β receptor ligand and tumor necrosis factor α. Journal of Virology73:1672–1681
    [Google Scholar]
  34. Zhu N., Khoshnan A., Schneider R., Matsumoto M., Dennert G., Ware C., Lai M. M.. 1998; Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. Journal of Virology72:3691–3697
    [Google Scholar]
  35. Zignego A. L., Bréchot C.. 1999; Extrahepatic manifestations of HCV infection: facts and controversies. Journal of Hepatology31:369–376
    [Google Scholar]
  36. Zignego A. L., Macchia D., Monti M., Thiers V., Mazzetti M., Foschi M., Maggi E., Romagnani S., Gentilini P., Bréchot C.. 1992; Infection of peripheral mononuclear blood cells by hepatitis C virus. Journal of Hepatology15:382–386
    [Google Scholar]
  37. Zignego A. L., Giannelli F., Marrocchi M. E., Mazzocca A., Ferri C., Giannini C., Monti M., Caini P., Villa G. L., Laffi G., Gentilini P.. 2000; T(14; 18) translocation in chronic hepatitis C virus infection. Hepatology31:474–479
    [Google Scholar]
  38. Zignego A., Ferri C., Giannelli F., Giannini C., Marrocchi M., Monti M., Caini P., La Villa G., Laffi G., Gentilini P.. 2002; Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B cell lymphoma. Annals of Internal Medicine (in Press)
    [Google Scholar]
  39. Zuckerman E., Zuckerman T., Sahar D., Streichman S., Attias D., Sabo E., Yeshurun D., Rowe J. M.. 2001; The effect of antiviral therapy on t(14; 18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood97:1555–1559
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-7-1665
Loading
/content/journal/jgv/10.1099/0022-1317-83-7-1665
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error